BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or OPTIMIZATION DAY , Switching from oral capsules to local sub cutaneous injection of BPC 157 to try and increase my bodys recovery capabilities since suffering a forearm tendon injury. , Ive been We're excited to now offer BPC 157 and Sermorelintwo powerful options to support healing, performance, and long term wellness. BPC 157 Available as a tablet or injection A synthetic peptide shown to support BPC 157 & TB 500: What You Need to Know